Myonexus Therapeutics Receives FDA Rare Pediatric Drug Designation for Pioneering Treatment of Limb Girdle Muscular Dystrophy Type 2E

World News: . []

Myonexus Therapeutics a clinical-stage gene therapy company developing first ever corrective gene therapies for limb girdle muscular dystrophies and Nationwide Childrens Hospital announced today that the US Food an d ...

More news and information about CincyTech

Published By:

Business Wire: 15:26 GMT Wednesday 16th May 2018

Published: .

Search for other references to "myonexus" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us